Research Progress on Hyperlipidemia
Advances in Clinical Medicine · 2024 · 14 (01) · 1635-1646
DOI: 10.12677/acm.2024.141235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical Medicine, 2024. Verfasst von 成消 李. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
This article provides a comprehensive review on the classification of hyperlipidemia, research progress in drug therapy, and the importance of diet and exercise management. Firstly, hyperlipidemia can be classified into primary and secondary types based on different etiological factors and genetic backgrounds. Secondly, significant progress has been made in drug therapy, including cholesterol-lowering drugs and triglyceride-lowering drugs. Statins are the cornerstone of cholesterol-lowering treatment, while other drugs such as cholesterol absorption inhibitors and PCSK9
Zitieren
APA
李, 成. (2024). Research Progress on Hyperlipidemia. Advances in Clinical Medicine, 14(01), 1635-1646. https://doi.org/10.12677/acm.2024.141235
Vancouver
李 成. Research Progress on Hyperlipidemia. Advances in Clinical Medicine. 2024;14(01):1635-1646. doi:10.12677/acm.2024.141235
BibTeX
@article{2024,
author = {李, 成消},
title = {Research Progress on Hyperlipidemia},
journal = {Advances in Clinical Medicine},
year = {2024},
volume = {14},
number = {01},
pages = {1635--1646},
doi = {10.12677/acm.2024.141235}
}
EUVIMED